HEADER TRANSFERASE/TRANSFERASE INHIBITOR 20-DEC-21 7WCL TITLE CRYSTAL STRUCTURE OF FGFR1 KINASE DOMAIN WITH PEMIGATINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: FGFR-1,BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1,BFGFR,BFGF- COMPND 5 R-1,FMS-LIKE TYROSINE KINASE 2,FLT-2,N-SAM,PROTO-ONCOGENE C-FGR; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, INHIBITOR, COMPLEX, STRUCTURAL PROTEIN, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX, TRA EXPDTA X-RAY DIFFRACTION AUTHOR X.J.CHEN,Q.M.LIN,L.Y.JIANG,L.Z.QU,Y.H.CHEN REVDAT 3 29-NOV-23 7WCL 1 REMARK REVDAT 2 08-FEB-23 7WCL 1 JRNL REVDAT 1 14-SEP-22 7WCL 0 JRNL AUTH Q.LIN,X.CHEN,L.QU,M.GUO,H.WEI,S.DAI,L.JIANG,Y.CHEN JRNL TITL CHARACTERIZATION OF THE CHOLANGIOCARCINOMA DRUG PEMIGATINIB JRNL TITL 2 AGAINST FGFR GATEKEEPER MUTANTS. JRNL REF COMMUN CHEM V. 5 100 2022 JRNL REFN ESSN 2399-3669 JRNL PMID 36698015 JRNL DOI 10.1038/S42004-022-00718-Z REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.87 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.3 REMARK 3 NUMBER OF REFLECTIONS : 21730 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1089 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.8660 - 4.9874 1.00 2866 136 0.1738 0.1934 REMARK 3 2 4.9874 - 3.9598 1.00 2793 130 0.1623 0.2031 REMARK 3 3 3.9598 - 3.4596 1.00 2737 182 0.1914 0.2168 REMARK 3 4 3.4596 - 3.1434 1.00 2751 138 0.2109 0.2495 REMARK 3 5 3.1434 - 2.9182 1.00 2741 132 0.2247 0.2776 REMARK 3 6 2.9182 - 2.7462 0.98 2672 146 0.2334 0.2671 REMARK 3 7 2.7462 - 2.6087 0.85 2324 128 0.2289 0.2999 REMARK 3 8 2.6087 - 2.4951 0.64 1757 97 0.2429 0.3123 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.19 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4811 REMARK 3 ANGLE : 0.694 6545 REMARK 3 CHIRALITY : 0.024 709 REMARK 3 PLANARITY : 0.004 835 REMARK 3 DIHEDRAL : 13.173 1819 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7WCL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-DEC-21. REMARK 100 THE DEPOSITION ID IS D_1300026464. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : CU FINE FOCUS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5870 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21761 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.495 REMARK 200 RESOLUTION RANGE LOW (A) : 39.870 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.06982 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.1300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 61.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.28760 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.050 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 4RWJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% (W/V) PEG 8000, 0.2 M LISO4, 0.1 M REMARK 280 MES (PH 6.5), VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 105.41550 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.79700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 105.41550 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.79700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 456 REMARK 465 PRO A 457 REMARK 465 ALA A 458 REMARK 465 GLU A 765 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 PRO B 591 REMARK 465 GLU B 592 REMARK 465 GLU B 593 REMARK 465 ALA B 645 REMARK 465 ARG B 646 REMARK 465 ASP B 647 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 465 HIS B 650 REMARK 465 ILE B 651 REMARK 465 ASP B 652 REMARK 465 GLN B 764 REMARK 465 GLU B 765 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 461 OG REMARK 470 GLU A 462 CG CD OE1 OE2 REMARK 470 ARG A 470 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 502 CG CD CE NZ REMARK 470 LYS A 504 CG CD CE NZ REMARK 470 ARG A 507 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 517 CG CD CE NZ REMARK 470 LYS A 542 CG CD CE NZ REMARK 470 GLU A 593 CG CD OE1 OE2 REMARK 470 GLU A 707 CG CD OE1 OE2 REMARK 470 GLU A 708 CG CD OE1 OE2 REMARK 470 LYS A 711 CG CD CE NZ REMARK 470 LEU A 712 CG CD1 CD2 REMARK 470 LYS A 714 CG CD CE NZ REMARK 470 LYS B 482 CG CD CE NZ REMARK 470 LYS B 502 CG CD CE NZ REMARK 470 LYS B 504 CG CD CE NZ REMARK 470 LYS B 510 CG CD CE NZ REMARK 470 LYS B 540 CG CD CE NZ REMARK 470 ARG B 570 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 594 CG CD OE1 NE2 REMARK 470 LYS B 618 CG CD CE NZ REMARK 470 GLU B 633 CG CD OE1 OE2 REMARK 470 LEU B 644 CG CD1 CD2 REMARK 470 THR B 657 OG1 CG2 REMARK 470 ARG B 661 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 675 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 711 CG CD CE NZ REMARK 470 LYS B 714 CG CD CE NZ REMARK 470 SER B 762 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASN B 659 CB - CA - C ANGL. DEV. = 12.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 486 -155.18 -126.78 REMARK 500 ARG A 622 -0.28 70.13 REMARK 500 ASP A 623 43.94 -156.07 REMARK 500 ASP B 468 84.29 -152.11 REMARK 500 PRO B 579 68.86 -102.16 REMARK 500 ARG B 622 -1.67 69.50 REMARK 500 ASP B 623 52.39 -155.83 REMARK 500 THR B 658 -146.60 -112.64 REMARK 500 THR B 678 -166.79 -126.49 REMARK 500 ASN B 724 -2.33 63.83 REMARK 500 REMARK 500 REMARK: NULL DBREF 7WCL A 458 765 UNP P11362 FGFR1_HUMAN 458 765 DBREF 7WCL B 458 765 UNP P11362 FGFR1_HUMAN 458 765 SEQADV 7WCL GLY A 456 UNP P11362 EXPRESSION TAG SEQADV 7WCL PRO A 457 UNP P11362 EXPRESSION TAG SEQADV 7WCL SER A 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQADV 7WCL GLY B 456 UNP P11362 EXPRESSION TAG SEQADV 7WCL PRO B 457 UNP P11362 EXPRESSION TAG SEQADV 7WCL SER B 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQRES 1 A 310 GLY PRO ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP SEQRES 2 A 310 PRO ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY SEQRES 3 A 310 LYS PRO LEU GLY GLU GLY CYS PHE GLY GLN VAL VAL LEU SEQRES 4 A 310 ALA GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG SEQRES 5 A 310 VAL THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA SEQRES 6 A 310 THR GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU SEQRES 7 A 310 MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN SEQRES 8 A 310 LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL SEQRES 9 A 310 ILE VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR SEQRES 10 A 310 LEU GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR SEQRES 11 A 310 ASN PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS SEQRES 12 A 310 ASP LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET SEQRES 13 A 310 GLU TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU SEQRES 14 A 310 ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET SEQRES 15 A 310 LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS SEQRES 16 A 310 ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO SEQRES 17 A 310 VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE SEQRES 18 A 310 TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU SEQRES 19 A 310 LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO SEQRES 20 A 310 GLY VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU SEQRES 21 A 310 GLY HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU SEQRES 22 A 310 LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SEQRES 23 A 310 SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU SEQRES 24 A 310 ASP ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 310 GLY PRO ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP SEQRES 2 B 310 PRO ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY SEQRES 3 B 310 LYS PRO LEU GLY GLU GLY CYS PHE GLY GLN VAL VAL LEU SEQRES 4 B 310 ALA GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG SEQRES 5 B 310 VAL THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA SEQRES 6 B 310 THR GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU SEQRES 7 B 310 MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN SEQRES 8 B 310 LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL SEQRES 9 B 310 ILE VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR SEQRES 10 B 310 LEU GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR SEQRES 11 B 310 ASN PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS SEQRES 12 B 310 ASP LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET SEQRES 13 B 310 GLU TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU SEQRES 14 B 310 ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET SEQRES 15 B 310 LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS SEQRES 16 B 310 ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO SEQRES 17 B 310 VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE SEQRES 18 B 310 TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU SEQRES 19 B 310 LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO SEQRES 20 B 310 GLY VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU SEQRES 21 B 310 GLY HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU SEQRES 22 B 310 LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SEQRES 23 B 310 SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU SEQRES 24 B 310 ASP ARG ILE VAL ALA LEU THR SER ASN GLN GLU HET 8ZF A 801 35 HET SO4 A 802 5 HET SO4 A 803 5 HET SO4 A 804 5 HET SO4 A 805 5 HET 8ZF B 801 35 HET SO4 B 802 5 HET SO4 B 803 5 HETNAM 8ZF 11-[2,6-BIS(FLUORANYL)-3,5-DIMETHOXY-PHENYL]-13-ETHYL- HETNAM 2 8ZF 4-(MORPHOLIN-4-YLMETHYL)-5,7,11,13- HETNAM 3 8ZF TETRAZATRICYCLO[7.4.0.0^{2,6}]TRIDECA-1(9),2(6),3,7- HETNAM 4 8ZF TETRAEN-12-ONE HETNAM SO4 SULFATE ION HETSYN 8ZF PEMIGATINIB FORMUL 3 8ZF 2(C24 H27 F2 N5 O4) FORMUL 4 SO4 6(O4 S 2-) FORMUL 11 HOH *90(H2 O) HELIX 1 AA1 GLY A 459 TYR A 463 5 5 HELIX 2 AA2 PRO A 474 ASP A 476 5 3 HELIX 3 AA3 THR A 521 GLY A 539 1 19 HELIX 4 AA4 ASN A 568 ALA A 575 1 8 HELIX 5 AA5 SER A 596 LYS A 617 1 22 HELIX 6 AA6 ALA A 625 ARG A 627 5 3 HELIX 7 AA7 LEU A 662 MET A 667 5 6 HELIX 8 AA8 ALA A 668 ARG A 675 1 8 HELIX 9 AA9 THR A 678 THR A 695 1 18 HELIX 10 AB1 PRO A 705 GLU A 715 1 11 HELIX 11 AB2 THR A 726 TRP A 737 1 12 HELIX 12 AB3 VAL A 740 ARG A 744 5 5 HELIX 13 AB4 THR A 746 THR A 761 1 16 HELIX 14 AB5 ALA B 458 TYR B 463 5 6 HELIX 15 AB6 PRO B 474 ASP B 476 5 3 HELIX 16 AB7 THR B 521 GLY B 539 1 19 HELIX 17 AB8 ASN B 568 ALA B 575 1 8 HELIX 18 AB9 SER B 596 LYS B 617 1 22 HELIX 19 AC1 ALA B 625 ARG B 627 5 3 HELIX 20 AC2 LEU B 662 TRP B 666 5 5 HELIX 21 AC3 ALA B 668 ASP B 674 1 7 HELIX 22 AC4 THR B 678 THR B 695 1 18 HELIX 23 AC5 PRO B 705 GLY B 716 1 12 HELIX 24 AC6 THR B 726 TRP B 737 1 12 HELIX 25 AC7 THR B 746 THR B 761 1 16 SHEET 1 AA1 5 LEU A 478 GLY A 485 0 SHEET 2 AA1 5 GLY A 490 ILE A 498 -1 O LEU A 494 N GLY A 481 SHEET 3 AA1 5 VAL A 508 LEU A 516 -1 O MET A 515 N GLN A 491 SHEET 4 AA1 5 TYR A 558 GLU A 562 -1 O VAL A 561 N ALA A 512 SHEET 5 AA1 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 AA2 2 VAL A 629 VAL A 631 0 SHEET 2 AA2 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 AA3 5 LEU B 478 GLY B 487 0 SHEET 2 AA3 5 GLY B 490 ILE B 498 -1 O LEU B 494 N LYS B 482 SHEET 3 AA3 5 VAL B 508 MET B 515 -1 O VAL B 513 N VAL B 493 SHEET 4 AA3 5 TYR B 558 VAL B 561 -1 O VAL B 561 N ALA B 512 SHEET 5 AA3 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560 SHEET 1 AA4 2 VAL B 629 VAL B 631 0 SHEET 2 AA4 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 CRYST1 210.831 49.594 66.804 90.00 107.50 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004743 0.000000 0.001496 0.00000 SCALE2 0.000000 0.020164 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015696 0.00000